Accendra Health Affirms FY2026 Sales Guidance of $2.450B-$2.550B vs $2.491B Est
Benzinga Newsdesk 12 hours ago
NewsGuidance
Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.450 billion-$2.550 billion to $2.450 billion-$2.550 billion vs $2.491 billion estimate.
Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.450 billion-$2.550 billion to $2.450 billion-$2.550 billion vs $2.491 billion estimate.